Bluejay Diagnostics (BJDX) Non Operating Income (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Non Operating Income of $19590.0 for Q1 2026, down 38.66% sequentially from $31935.0 in Q4 2025, and down 19.98% YoY from $24482.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Non Operating Income (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Non Operating Income for 7 years, with the latest figure at $19590.0 in Q1 2026.
- Quarterly Non Operating Income fell 19.98% year-over-year to $19590.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99597.0 (up 115.98% YoY) and the FY2025 annual result came in at $104489.0, up 119.06% from the prior year.
- Non Operating Income fell to $19590.0 in Q1 2026 per BJDX's latest filing, from $31935.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $139729.0 in Q1 2023 and troughed at -$580119.0 in Q2 2024.
- A 5-year average of -$2702.4 and a median of $43235.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income jumped 176.9% in 2022, then tumbled 741.85% in 2024.
- Over 5 years, Non Operating Income stood at $67358.0 in 2022, then increased by 24.68% to $83982.0 in 2023, then plunged by 37.3% to $52654.0 in 2024, then plunged by 39.35% to $31935.0 in 2025, then sank by 38.66% to $19590.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $19590.0, $31935.0, and $19315.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | 25,111.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25,111.00 |
| Mar 31, 2026 | 19,590.00 |
| Dec 31, 2025 | 31,935.00 |
| Sep 30, 2025 | 19,315.00 |
| Jun 30, 2025 | 28,757.00 |
| Mar 31, 2025 | 24,482.00 |
| Dec 31, 2024 | 52,654.00 |
| Sep 30, 2024 | -120,352.00 |
| Jun 30, 2024 | -580,119.00 |
| Mar 31, 2024 | 99,640.00 |
| Dec 31, 2023 | 83,982.00 |
| Sep 30, 2023 | 43,235.00 |
| Jun 30, 2023 | 90,383.00 |
| Mar 31, 2023 | 139,729.00 |
| Dec 31, 2022 | 67,358.00 |
| Sep 30, 2022 | -149,711.00 |
| Jun 30, 2022 | 48,323.00 |
| Mar 31, 2022 | 54,858.00 |
| Dec 31, 2021 | -87,591.00 |
| Sep 30, 2021 | -235,393.00 |